Table 1 Summary of Included Studies (n = 77)
From: A review of health utilities across conditions common in paediatric and adult populations
Condition | Population | No. of studies* | Utility Measure | Study Design (No. of studies*) |
|---|---|---|---|---|
Asthma | Adults & children/adolescents | 5 | EQ-5D | RCT (1) |
| Â | Â | Â | HUI | cross-sectional (3) |
| Â | Â | Â | SG | cross-sectional (1) |
| Â | Children/adolescents | 1 | HUI | non-randomized cohort (1) |
| Â | Â | Â | SG | non-randomized cohort (1) |
| Â | Adults | 19 | EQ-5D | non-randomized cohort (2); cross-sectional (9) |
| Â | Â | Â | HUI | cross-sectional (4) |
| Â | Â | Â | SG | cohort (2); cross-sectional (3) |
| Â | Â | Â | TTO | cross-sectional (4) |
Cancer | Adults & children/adolescents | 11 | HUI | cross-sectional (11) |
| Â | Children/adolescents | 12 | HUI | non-randomized cohort (4); cross-sectional (8) |
| Â | Â | Â | SG | cross-sectional (1) |
| Â | Â | Â | TTO | cross-sectional (1) |
Chronic disease | Children/adolescents | 2 | HUI | cross-sectional (2) |
| Â | Â | Â | TTO | cross-sectional (1) |
Diabetes | Children/adolescents | 1 | EQ-5D | non-randomized cohort (1) |
| Â | Adults | 10 | EQ-5D | non-randomized cohort (1); cross-sectional (5) |
| Â | Â | Â | HUI | cross-sectional (1) |
| Â | Â | Â | SG | cross-sectional (1) |
| Â | Â | Â | TTO | cross-sectional (3) |
Skin diseases | Adults & children/adolescents | 2 | EQ-5D | cross-sectional (1) |
| Â | Â | Â | HUI | cross-sectional (1) |
| Â | Children/adolescents | 2 | SG | cross-sectional (1) |
| Â | Â | Â | TTO | cross-sectional (1) |
| Â | Adult | 15 | EQ-5D | RCT (4); non-randomized (1); cross-sectional (2) |
| Â | Â | Â | SG | cross-sectional (2); cohort (1); test-retest cohort (1) |
| Â | Â | Â | TTO | cross-sectional (5); cohort (1); pre-post (1) |